ZTS - Zoetis Inc.
172.24
0.230 0.134%
Share volume: 2,676,216
Last Updated: Tue 04 Feb 2025 10:00:00 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.24%
PREVIOUS CLOSE
CHG
CHG%
$172.01
0.30
0.00%
Fundamental analysis
81%
Profitability
87%
Dept financing
41%
Liquidity
75%
Performance
87%
Performance
5 Days
0.78%
1 Month
3.82%
3 Months
-1.73%
6 Months
-1.48%
1 Year
-9.43%
2 Year
4.43%
Key data
Stock price
$172.24
DAY RANGE
$170.11 - $173.15
52 WEEK RANGE
$144.80 - $200.53
52 WEEK CHANGE
-$12.61
DIVIDEND
$0.50
EX-DIVIDEND DATE
01/21/2025
NEXT EARNINGS DATE
N/A
Company detail
CEO: Kristin C. Peck
Region: US
Website: zoetis.com
Employees: 13,800
IPO year: 2013
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: zoetis.com
Employees: 13,800
IPO year: 2013
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts.
Recent news